We next sought to verify on-target activity of ATR inhibitors on ATR kinase activity as a mechanism of the observed cell cycle disruption, replication stress exacerbation and genomic instability in ARMS cells. The gene discussed is ATR; the disease is alveolar rhabdomyosarcoma.